Reasearch programme: small molecule therapeutics - Dorian Therapeutics/HitGen
Latest Information Update: 14 Jun 2021
At a glance
- Originator Dorian Therapeutics; HitGen
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Unspecified